Literature DB >> 9200154

Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones.

E M Schmelz1, A S Bushnev, D L Dillehay, D C Liotta, A H Merrill.   

Abstract

Supplementation of the diet of CF1 mice with sphingomyelin isolated from milk has been shown to reduce the number of aberrant crypt foci (ACF) and the appearance of colonic adenocarcinoma induced by 1,2-dimethylhydrazine (Schmelz et al., Cancer Res 56, 4936-4941, 1996). The objective of this study was to determine whether chemically synthesized sphingomyelin reduces the appearance of ACF, one of the earliest morphological changes in the development of colonic tumors, and to investigate the specificity of this inhibition for the unsaturated sphingoid base backbone. 1,2-Dimethylhydrazine was administered intraperitoneally to female CF1 mice, then the animals were fed a semipurified AIN 76A diet without supplementation (controls) or supplemented with 0.1% (wt/wt) sphingomyelin isolated from skim milk powder, synthetic N-palmitoylsphingomyelin, or N-palmitoyldihydrosphingomyelin for four weeks. The number of ACF in the sphingomyelin-fed groups was significantly lower than in the control by 54% (p = 0.002), 52% (p = 0.002), and 70% (p < 0.0001) for milk sphingomyelin, synthetic sphingomyelin, and synthetic dihydrosphingomyelin, respectively. Suppression of ACF by the synthetic dihydrosphingomyelin was significantly greater than by synthetic sphingomyelin (p = 0.035). These findings establish that sphingomyelin, and not merely a possible contaminant of the naturally occurring sphingomyelin preparation used previously, suppresses ACF formation. Furthermore, the greater potency of dihydrosphingomyelin reveals that the 4,5-trans double bond of the sphingoid backbone is not required for this suppression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200154     DOI: 10.1080/01635589709514556

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  11 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.

Authors:  Masataka Kohno; Michiko Momoi; Myat Lin Oo; Ji-Hye Paik; Yong-Moon Lee; Krishnan Venkataraman; Youxi Ai; Ari P Ristimaki; Henrik Fyrst; Hajime Sano; Daniel Rosenberg; Julie D Saba; Richard L Proia; Timothy Hla
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

3.  Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expression.

Authors:  Joseph C Mazzei; Hui Zhou; Bradley P Brayfield; Raquel Hontecillas; Josep Bassaganya-Riera; Eva M Schmelz
Journal:  J Nutr Biochem       Date:  2011-02-04       Impact factor: 6.048

4.  Milk Fermented by Lactic Acid Bacteria Enhances the Absorption of Dietary Sphingomyelin in Rats.

Authors:  Masashi Morifuji; Masami Kitade; Chisato Oba; Tomoyuki Fukasawa; Keiko Kawahata; Taketo Yamaji; Yuki Manabe; Tatsuya Sugawara
Journal:  Lipids       Date:  2017-03-29       Impact factor: 1.880

5.  Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis.

Authors:  Jun Wu; Gert H Hansen; Ake Nilsson; Rui-Dong Duan
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

6.  Reduced levels of the adenomatous polyposis coli (APC) protein are associated with ceramide-induced apoptosis of colon cancer cells.

Authors:  Aruna S Jaiswal; Satya Narayan
Journal:  J Cancer Res Clin Oncol       Date:  2004-08-31       Impact factor: 4.553

Review 7.  Sphingolipids in colon cancer.

Authors:  Mónica García-Barros; Nicolas Coant; Jean-Philip Truman; Ashley J Snider; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-09-21

8.  Milk Phospholipids Enhance Lymphatic Absorption of Dietary Sphingomyelin in Lymph-Cannulated Rats.

Authors:  Masashi Morifuji; Seiichiro Higashi; Chisato Oba; Satomi Ichikawa; Keiko Kawahata; Taketo Yamaji; Hiroyuki Itoh; Yuki Manabe; Tatsuya Sugawara
Journal:  Lipids       Date:  2015-08-02       Impact factor: 1.880

9.  Regulation of beta-catenin and connexin-43 expression: targets for sphingolipids in colon cancer prevention.

Authors:  Kirk W Simon; Paul C Roberts; Michael J Vespremi; Steve Manchen; Eva M Schmelz
Journal:  Mol Nutr Food Res       Date:  2009-03       Impact factor: 5.914

10.  Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.

Authors:  Angela S Anderson; Paul C Roberts; Madlyn I Frisard; Ryan P McMillan; Timothy J Brown; Michael H Lawless; Matthew W Hulver; Eva M Schmelz
Journal:  Exp Cell Res       Date:  2013-03-19       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.